Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?

被引:0
|
作者
Liakou, Aikaterini I. [1 ]
Tsantes, Andreas G. [2 ,3 ]
Routsi, Eleni [1 ]
Agiasofitou, Efthymia [1 ]
Kalamata, Magdalini [1 ]
Bompou, Evangelia-Konstantina [1 ]
Tsante, Konstantina A. [2 ]
Vladeni, Soultana [1 ]
Chatzidimitriou, Eleni [1 ]
Kotsafti, Ourania [1 ]
Samonis, George [4 ,5 ]
Bonovas, Stefanos [6 ,7 ]
Stratigos, Alexander I. [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Andreas Sygros Hosp, Med Sch, Dept Dermatol Venereol 1, Athens 16121, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Hosp, Med Sch, Lab Haematol & Blood Bank Unit, Athens 12462, Greece
[3] St Savvas Oncol Hosp, Microbiol Dept, Athens 11522, Greece
[4] Univ Crete, Dept Med, Iraklion 71500, Greece
[5] Metropolitan Hosp, Dept Oncol, Athens 18547, Greece
[6] Humanitas Univ, Dept Biomed Sci, I-20072 Milan, Italy
[7] IRCCS, Humanitas Res Hosp, Milan, Italy
关键词
immune-mediated inflammatory diseases; COVID-19; vaccine; flare; onset; hidradenitis;
D O I
10.3390/jcm13164617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exacerbations and new onset of immune-mediated inflammatory diseases, such as psoriasis and hidradenitis suppurativa, have been reported following COVID-19 vaccination. In patients with hidradenitis suppurativa, recent studies have shown that those who received mRNA vaccines were 3.5 times as likely to develop flares following vaccination compared to patients who received non-mRNA vaccines, indicating that mRNA COVID-19 vaccines are associated with hidradenitis suppurativa flares. Similar findings have been found in other studies evaluating the association between COVID-19 vaccines and other immune-mediated inflammatory diseases such as psoriasis, atopic dermatitis, lichen planus, and alopecia areata. However, further research is warranted in larger populations to validate these findings.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Exacerbation of Immune-mediated Inflammatory Diseases in COVID19 Sequelae
    Caetano, Camila
    Azamor, Tamiris
    Meyer, Nikki M.
    Calabrese, Cassandra
    Calabrese, Leonard
    Piuzzi, Nicolas
    Husni, M. Elaine
    Foo, Suan-Sin
    Chen, Weiqiang
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3317 - 3318
  • [32] COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases
    Pinte, Larisa
    Caraiola, Simona
    Balaban, Daniel Vasile
    Badea, Camelia
    Mazilu, Diana
    Ionescu, Georgeta Daniela
    Iosub, Maria-Ilinca
    Balan, Elena-Sabina
    Negoi, Florentina
    Dumitrescu, Bianca
    Mateescu, Bogdan
    Ionescu, Ruxandra
    Parvu, Magda Ileana
    Baicus, Cristian
    HEALTHCARE, 2021, 9 (12)
  • [33] The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease
    Sahn, Benjamin
    Lu, Ying
    Hui-Yuen, Joyce S. S.
    Fishbein, Joanna
    Gottlieb, Beth S. S.
    Eberhard, Barbara A. A.
    Walters, Heather M. M.
    ACTA PAEDIATRICA, 2023, 112 (04) : 794 - 801
  • [34] Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
    Picod, Adrien
    Rebibou, Jean-Michel
    Dossier, Antoine
    Cador, Berengere
    Ribes, David
    Vasco-Moynet, Claire
    Stephan, Caroline
    Bellal, Mathieu
    Wynckel, Alain
    Poullin, Pascale
    Peju, Edwige
    Ricard, Laure
    Kahn, Jean-Emmanuel
    Bouzid, Raida
    Benhamou, Ygal
    Joly, Berangere
    Veyradier, Agnes
    Coppo, Paul
    BLOOD, 2022, 139 (16) : 2565 - +
  • [35] IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES TAKING A BIOLOGIC THERAPY
    Halioua, B.
    Zetlaoui, J.
    Astruc, A.
    Testa, D.
    Bombezin-Domino, A.
    Radoszycki, L.
    VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [36] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
    Torres, Tiago
    Puig, Luis
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 307 - 311
  • [37] COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
    Gauckler, Philipp
    Kesenheimer, Jana S.
    Geetha, Duvuru
    Odler, Balazs
    Eller, Kathrin
    Laboux, Timothee
    Alberici, Federico
    Zappa, Mattia
    Chebotareva, Natasha
    Moiseev, Sergey
    Bonilla, Marco
    Jhaveri, Kenar D.
    Oniszczuk, Julie
    Audard, Vincent
    Costa, Denise
    Mastroianni-Kirsztajn, Gianna
    Bruchfeld, Annette
    Muto, Masahiro
    Windpessl, Martin
    Mayer, Gert
    Kronbichler, Andreas
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
    Tiago Torres
    Luis Puig
    American Journal of Clinical Dermatology, 2020, 21 : 307 - 311
  • [39] Symptoms of COVID-19 in Patients with Immune Mediated Inflammatory Diseases
    Schlosser, T.
    Krasselt, M.
    Elsing, L.
    Hecker, M.
    Holler, B.
    Hoffmeister, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 950 - 952
  • [40] Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
    Schlosser, Tobias
    Krasselt, Marco
    Elsing, Louis
    Hecker, Martin
    Holler, Babett
    Hoffmeister, Albrecht
    AUTOIMMUNE DISEASES, 2024, 2024